ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis

Zhuo Chen, Sheng-Hua Yang, Hao Xu, Jian-Jun Li, Zhuo Chen, Sheng-Hua Yang, Hao Xu, Jian-Jun Li

Abstract

ABO blood group system, a well-known genetic risk factor, has clinically been demonstrated to be linked with thrombotic vascular diseases. However, the relationship between ABO blood group and coronary artery disease (CAD) is still controversial. We here performed an updated meta-analysis of the related studies and tried to elucidate the potential role of ABO blood group as a risk factor for CAD. All detectable case-control and cohort studies comparing the risk of CAD in different ABO blood groups were collected for this analysis through searching PubMed, Embase, and the Cochrane Library. Ultimately, 17 studies covering 225,810 participants were included. The combined results showed that the risk of CAD was significantly higher in blood group A (OR = 1.14, 95% CI = 1.03 to 1.26, p = 0.01) and lower in blood group O (OR = 0.85, 95% CI = 0.78 to 0.94, p = 0.0008). Even when studies merely about myocardial infarction (MI) were removed, the risk of CAD was still significantly higher in blood group A (OR = 1.05, 95% CI = 1.00 to 1.10, p = 0.03) and lower in blood group O (OR = 0.89, 95% CI = 0.85 to 0.93, p < 0.00001). This updated systematic review and meta-analysis indicated that both blood group A and non-O were the risk factors of CAD.

Figures

Figure 1. Flow-chart of study selection.
Figure 1. Flow-chart of study selection.
Figure 2. Forest plot of blood group…
Figure 2. Forest plot of blood group A.
Figure 3. Forest plot of blood group…
Figure 3. Forest plot of blood group B.
Figure 4. Forest plot of blood group…
Figure 4. Forest plot of blood group AB.
Figure 5. Forest plot of blood group…
Figure 5. Forest plot of blood group O.
Figure 6. Funnel plot of blood group…
Figure 6. Funnel plot of blood group O.

References

    1. Lesky E. Viennese serological research about the year 1900: its contribution to the development of clinical medicine. Bull N Y Acad Med 49, 100–111 (1973).
    1. Alexander K. S. et al.. ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. Neurology 83, 1271–1276 (2014).
    1. Alpoim P. N. et al.. Preeclampsia and ABO blood groups: a systematic review and meta-analysis. Mol Biol Rep 40, 2253–2261 (2013).
    1. Liumbruno G. M. & Franchini M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis 38, 160–166 (2014).
    1. Franchini M. & Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clin Chim Acta 444, 66–71 (2015).
    1. Dentali F. et al.. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 38, 535–548 (2012).
    1. Jenkins P. V. & O’Donnell J. S. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 46, 1836–1844 (2006).
    1. Dentali F., Sironi A. P., Ageno W., Crestani S. & Franchini M. ABO blood group and vascular disease: an update. Semin Thromb Hemost 40, 49–59 (2014).
    1. Wu O., Bayoumi N., Vickers M. A. & Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 6, 62–69 (2008).
    1. Takagi H. & Umemoto T. Meta-analysis of non-O blood group as an independent risk factor for coronary artery disease. Am J Cardiol 116, 699–704 (2015).
    1. Chen Y. et al.. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ Cardiovasc Genet 7, 43–48 (2014).
    1. Sode B. F., Allin K. H., Dahl M., Gyntelberg F. & Nordestgaard B. G. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ 185, 229–237 (2013).
    1. Biswas S., Ghoshal P. K., Halder B. & Mandal N. Distribution of ABO blood group and major cardiovascular risk factors with coronary heart disease. Biomed Res Int 2013, 782941 (2013).
    1. Lee H. F. et al.. Association of blood group A with coronary artery disease in young adults in Taiwan. Intern Med 51, 1815–1820 (2012).
    1. He M. et al.. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 32, 2314–2320 (2012).
    1. Sari I. et al.. ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction. Blood Coagul Fibrin 19, 231–234 (2008).
    1. Tanis B., Algra A., van der Graaf Y., Helmerhorst F. & Rosendaal F. Procoagulant factors and the risk of myocardial infarction in young women. Eur J Haematol 77, 67–73 (2006).
    1. Amirzadegan A. et al.. Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol 110, 256–258 (2006).
    1. Nydegger U. E., Wuillemin W. A., Julmy F., Meyer B. J. & Carrel T. P. Association of ABO histo-blood group B allele with myocardial infarction. Eur J Immunogenet 30, 201–206 (2003).
    1. Platt D., Muhlberg W., Kiehl L. & Schmitt-Ruth R. ABO blood group system, age, sex, risk factors and cardiac infarction. Arch Gerontol Geriatr 4, 241–249 (1985).
    1. Saha N., Toh C. C. & Ghosh M. B. Genetic association in myocardial infarction. Ethnicity; ABO, Rh, Le, Xg blood groups; G6PD deficiency; and abnormal haemoglobins. J Med Genet 10, 340–345 (1973).
    1. Allan T. M. & Dawson A. A. ABO blood groups and ischaemic heart disease in men. Br Heart J 30, 377–382 (1968).
    1. Gjorup L. Blood groups and coronary occlusion. Acta Genet Stat Med 13, 178–183 (1963).
    1. Pell S. & D’Alonzo C. A. A three-year study of myocardial infarction in a large employed population. JAMA 175, 463–470 (1961).
    1. Franchini M. et al.. ABO blood group and risk of coronary artery disease. J Thromb Thrombolys 36, 286–287 (2013).
    1. Gong P. et al.. High-sensitivity C-reactive protein mediates in part the impact of ABO blood group on coronary artery disease. Int J Cardiol 177, 641–643 (2014).
    1. Higgins J. P., Thompson S. G., Deeks J. J. & Altman D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557 (2003).
    1. Whincup P. H., Cook D. G., Phillips A. N. & Shaper A. G. ABO blood group and ischaemic heart disease in British men. BMJ 300, 1679–1682 (1990).
    1. Wazirali H., Ashfaque R. A. & Herzig J. W. Association of blood group A with increased risk of coronary heart disease in the pakistani population. Pak J Physiol 1, 1–2 (2005).
    1. Yu B. & Lin G. A correlation research on Uyghur coronary heart disease patients and ABO blood genetic phenotype. J Xinjiang Med Univ 36, 808–810 (2013).
    1. Gill J. C., Endres-Brooks J., Bauer P. J., Marks W. J. Jr. & Montgomery R. R. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69, 1691–1695 (1987).
    1. Dentali F. et al.. Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost 39, 72–82 (2013).
    1. Reilly M. P. et al.. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 377, 383–392 (2011).
    1. Gong P. et al.. [Total cholesterol mediates the effect of ABO blood group on coronary heart disease]. Zhonghua Xin Xue Guan Bing Za Zhi 43, 404–407 (2015).
    1. Stroup D. F. et al.. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283, 2008–2012 (2000).
    1. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603–605 (2010).

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner